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Cosmetics have been used since the very first days of human life. This early and continuing consumption 
has resulted in the growth of the Cosmetic Industry (C.I.). The C.I. must continue to invest in the 
development of innovative products which are safe for the consumers. On the other hand, the Health 
Agency should issue laws regulating the development of products. Thus, the aim of this study was to 
evaluate the Brazilian Cosmetic Legislation before ANVISA and the challenges for the C.I. during the 
20th century regarding the development of safe and effective cosmetics, and to show the importance of 
this legislation in the R&D. A Bibliographic and Documentary Exploratory Research was conducted 
based on safety and efficacy data contained in scientific studies and legal documents. The study showed 
that the creation of ANVISA was necessary because no resolution had been published about the safety 
and efficacy of cosmetics for the C.I. before ANVISA. However, the challenges faced by the C.I. may 
have had a negative impact on the health of consumers. Finally, it was concluded that the actions before 
ANVISA were insufficient to the C.I.. Thus, the creation of ANVISA was essential to have a regulatory 
basis fot the C.I. 
Uniterms: Brazil/Sanitary Agency/cosmetics production. Brazil/cosmetic legislation. Cosmetics/safety 
production. Cosmetic industry.
Os cosméticos são usados desde os primeiros dias de vida do ser humano. Consequentemente, esse 
consumo resulta no crescimento da Indústria Cosmética (I.C.). Com isso, a I.C. deve focar seus 
investimentos também no desenvolvimento de produtos inovadores, mas, acima de tudo, seguros para 
os consumidores. Por outro lado, a Agência Sanitária deve emitir leis que regulam o desenvolvimento 
desses produtos. Assim, o objetivo deste estudo foi avaliar a Legislação Cosmética Brasileira anterior 
à ANVISA e os desafios da I.C. no século XX no desenvolvimento de produtos cosméticos seguros e 
eficazes, bem como mostrar a importância dessa legislação na P&D. Para tal, realizou-se uma Pesquisa 
Exploratória Bibliográfica e Documental com base em estudos científicos e documentos legais. Dessa 
forma, o estudo mostrou que a criação da ANVISA foi necessária porque nenhuma resolução tinha sido 
publicada sobre a segurança e eficácia de cosméticos antes da ANVISA. Com isso, os desafios enfrentados 
pela I.C. poderiam ter um impacto negativo sobre a saúde dos consumidores. Por fim, concluiu-se que 
as ações anteriores à ANVISA foram insuficientes para a I.C. Assim, a criação da ANVISA foi essencial 
para ter uma base regulatória para a I.C..
Unitermos: Brasil/Agência Sanitária/produção de cosméticos. Brasil/legislação de cosméticos. 
Cosméticos/produção/segurança. Indústria cosmética.
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INTRODUCTION
Considered essential products, hygiene products, 
perfumes and cosmetics, in this study referred to as 
“cosmetic products”, have been present since the very 
first days of human life, mainly related to daily hygiene. 
On the other hand, cosmetic products also contribute 
to the maintenance or improvement of health because 
they protect against environmental damage such as solar 
radiation or low humidity, they correct imperfections of 
the skin and contributeto self-esteem.
This early and continuing consumption has resulted 
in the growth of the Cosmetic Industry. According to 
ABIHPEC,from 1996 to 2012 the Brazilian Cosmetic 
Industry has shown a growth of 10% per year compared to 
a 2.2% growth per year of the other industries (ABIHPEC, 
2013).
This growth may be the result of several factors 
such as the increasing income of the D and E classes 
and the consumption of products with ‘added value’, 
the participation of women in the labor market, and 
productivity. In addition, the different technologies 
available to launch new products, the increased life 
expectancy, the search for rejuvenation, the awareness of 
the need for sun protection and the Brazilian exports have 
led to an increasing supply of products (ABIHPEC, 2013).
However, this subject should not be evaluated only 
from an economic perspective, but the development of 
safe and effective products should also be encouraged. 
Therefore, the Cosmetic Industry should continue to 
invest in the development of innovative products which 
are safe for the consumers. In addition, the Health 
Agency should issue laws for the development and 
marketing of products according to available standards 
and guidelines, following Good Manufacturing Practices, 
and regulating these products by completing Safety and 
Efficacy Studies.
The Brazilian Health Surveillance Agency 
(ANVISA) was created by law No 9782 of January 26, 
1999 (Brasil, 1999). The creation of ANVISA aimed to 
centralize actions regarding sanitary regulation in order 
to determine how products and services can impact on 
people’s health, including those of the Cosmetic Industry. 
However, to understand the creation of ANVISA and its 
importance for the cosmetic area, it was necessary to 
evaluate the legislation, focusing on publications related 
to the safety and efficacy of cosmetic products.
In addition to specific publications in this area, 
publications ofrelated areas were also evaluated, as well 
as non-regulatory publications that had a significant 
impact on the regulation of these products. Thus, the 
present literature and the documents from exploratory 
research have provided relevant information for the 
industrial and scientific community and have contributed 
to the consolidation of the importance of ANVISA for the 
continuous monitoring, assessment, guidance, regulation 
of research, development and innovation (RD&I) and 
marketing of safe and effective cosmetic products.
OBJECTIVE
The aim of this study was to evaluate the Brazilian 
Cosmetic Legislation before the creation of ANVISA and 
the challenges for the Cosmetic Industry during the 20th 
century regarding the development of safe and effective 
cosmetic products, as well as to show the importance 
of knowledge of health legislation in the Research 
Development and Innovation (RD&I) area.
MATERIAL AND METHODS
Evaluation of the Brazilian Cosmetic Legislation 
beforethe creation of ANVISA
Exploratory Research
The Brazilian Cosmetic Legislation was evaluated 
by Bibliographic and Documentary Exploratory Research 
(Raupp, Beuren, 2003; Sá-Silva, Almeida, Guindani, 
2009) based on available safety and efficacy data. The 
Exploratory Research was chosen in order to obtain a 
broad view of the subject under study (Gil, 2008), i.e., 
the Cosmetic Legislation in Brazil before ANVISA. In 
addition, according to Raupp, Beuren (2003), this research 
is defined as an initial survey, in which the researchers 
observe any important information and seek to understand 
more about this subject.
The choice of this type of research involved 
investigations published in the area, such as research 
about hospital law (Feldstein, Melnick, 1984), the 
problems of legislation (Lorenzo, 1994), the impact of 
legislation on small businesses (Heriot, Lang, Thompson, 
2010), as well as European and United States legislation 
about Phototoxicity Studies (Seto et al., 2012). Thus, 
we evaluated data contained in books, articles, theses 
(Bibliographic Exploratory Research) and decrees, 
laws, rules and resolutions (Documentary Exploratory 
Research).
Data analysis
The results were organized in a chronological 
comparison of regulatory milestones in the cosmetic area 
and related areas.
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RESULTS AND DISCUSSION
Figure 1 shows the main legislation and milestones 
of the cosmetic area in the 20th century until the creation 
of ANVISA.
In Brazil, the first decade of the 20thcentury was 
marked by the first phase of the Sanitary Movement, when 
Oswaldo Cruz was Chief Executive of Public Health for 
the urban sanitation of the Rio de Janeiro (FUNASA, 
2004; 2014; Hamilton, Fonseca, 2003; Lima, Pinto, 2003; 
Stuart, 1914). At that time, the regulation of the Brazilian 
Health Services was defined (Brasil, 1904; Rozenfeld, 
2000).
In 1910, the second phase of the Sanitary Movement 
was characterized by rural sanitation and the initiatives 
of the Oswaldo Cruz Institute with scientific expeditions 
to various parts of the country to learn about the health 
of the population. In this phase, the organization of a 
specific Ministry of Health was also under discussion in 
the National Congress (Hamilton, Fonseca, 2003; Lima, 
Pinto, 2003).
In addition, several health surveys were conducted 
early in the 20th century in Brazil, mainly in São Paulo, 
regarding the control of medicines, foods and shops 
(Rozenfeld, 2000; Stuart, 1914), including those selling 
cosmetic products.
Despite these actions, due to the precarious health 
and diseases of the population, the focus of the legislation 
was mainly on hygiene and health issues.
In 1920, the Decree-Law No 3987 was published 
by the National Department of Public Health (DNSP), 
under the Ministry of Justice and Internal Affairs, 
replacing the General Directorate of Public Health, 
which was established in 1897. With this decree, the 
DNSP became responsible for the actions on health 
surveillance, including urban and rural sanitation; 
child care services; the supervision of industrial and 
professional hygiene; the supervision of pharmaceuticals 
and other health-related products for sale; the supervision 
of hospitals; the supervision of health-related advertising; 
and the control of endemic and epidemic diseases (Brasil, 
1920; Rozenfeld, 2000).
However, the actions of the DNSP were not 
successful due to the limitations of the country, with the 
1920 Census indicating the presence of 13336 industries 
in Brazil. The food industry occupied first place, but the 
foreign chemical-pharmaceutical industry began to settle 
in the country (Souza, 1927; Rozenfeld, 2000).
Decree No16300 was published in 1923 and 
the actions of the DNSP were supplemented and 
restructured. Thus, the professional inspection of 
drugstores, pharmacies, laboratories and industries was 
regulated, as well as the licensing and inspection of 
pharmaceutical products, cosmetics and other health-
related products (Brasil, 1923).
The focus on industrial hygiene issues was important 
because the absence of control in industrial establishments 
could also expose consumers to health risks. Thus, the 
industry, particularly the Pharmaceutical Industry, and its 
products began to be monitored. This control led to the 
first actions of punishment, as well as orientation of the 
industrial area.
In 1930, with the emergence of the new Brazilian 
state, characterized as a strong and centralized state, 
industrialization represented a form of development, 
with a significant growth of the Chemical-Pharmaceutical 
Industry (Rozenfeld, 2000), as also observed in other 
countries. This decade represented the beginning of the 
“Golden Age” of the Pharmaceutical Industry.
The industrial growth resulted from political and 
economic issues, but the Cosmetic Industry remained 
unregulated, without specific guidance about GMP and 
the development of safe and effective products.
During the same period, Decree No19402 created 
the Ministry of Education and Public Health (MESP), 
FIGURE 1 - Overview of the regulatory milestones in the 20th 
century before ANVISA.
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representing the control of public health linked to 
education (Brasil, 1930; FUNASA, 2004; 2014; 
Hochman, 2005), but the proposal of health centralization 
was still under discussion (Hamilton, Fonseca, 2003).
All public health actions were concentrated in this 
new Ministry and the DNSP was incorporated into it 
(FUNASA, 2004; 2014). According to Hochman (2005), 
the creation of the MESP did not represent changes in 
public health because it only incorporated the DNSP and, 
at the end of the Provisional Government, it still had no 
defined objectives.
However, during the administration of MESP by 
Gustavo Capanema, significant reforms occurred, such 
as new directions and the restructuring of the public 
health administration. The Ministry was renamed 
Ministry of Education and Health (MES) and the DNSP 
was renamed National Department of Health (DNS). In 
addition, the Federal Police Health Stations were created, 
which were designed to inspect health actions, as well as 
health facilities. The National Health Conference (CNS) 
proposed the meeting of delegations from all states to 
discuss issues related to public health and the National 
Health Service was created, being responsible for fighting 
diseases and holding campaigns to prevent epidemics 
(Brasil, 1941b; Pandolfi, 1999; Hochman, 2005).
In 1941, during the 1st National Health Conference 
in Rio de Janeiro (Brasil, 1941a), some representatives 
from Brazilian regions questioned the lack of a discussion 
about the creation of a specific Ministry of Health 
(Hamilton; Fonseca, 2003). Over the following years, the 
discussion about the creation of a separate Ministry of 
Health continued, mainly among physicians and health 
workers (Garret et al., 1995). It intensified with the end 
of World War II, as a result of “sanitary optimism” and 
with the advances in the development of vaccines and 
in the control of infectious diseases (Macnalty, 1952; 
Garret et al, 1995).
After four decades of the Sanitary Movement, the 
discussion about the creation of a Ministry centralized on 
health issues was still considered necessary. The reforms 
made did not meet all the needs of the Brazilian Health 
Surveillance, including those related to the Cosmetic 
Industries. Thus, Decree No 20397 was published 
to regulate the Pharmaceutical Industry. This decree 
regulates the marketing of pharmaceuticals and other 
health-related products, including cosmetics, which could 
then be marketed after submission to safety evaluation. 
The standardization of the industry supervision, licenses 
and the requirement of a responsible pharmacist in these 
establishments were also included in this document 
(Brasil, 1946).
The regulation of the Pharmaceutical Industry also 
provided a regulatory basis for the Cosmetic Industry 
and for the first time safety evaluation was required 
before marketing a product. However, no guidance was 
available about the studies. In addition, this regulation 
did not include any issues related to the efficacy of these 
products. Thus, the Cosmetic Industry had no guidance for 
the development of safe and effective products, but was 
forced to regulate them with safety studies.
In 1952, the second government of Getúlio Vargas 
determined changes in state structure and proposed a new 
portfolio for health. This resulted in discussions about 
the incorporation of Public Health into the Health Care 
Services of Social Security, creating the Ministry of Social 
Services (Hamilton, Fonseca, 2003).
In 1953, the political crisis in the government 
resulted in an emergency action with the project previously 
presented being approved by the Senate, and the on July 
25, 1953, Law No 1920 created the Ministry of Health 
(MS) (Brasil, 1953; Hamilton; Fonseca, 2003).
All the organs and services of MES were transferred 
to the MS, including the National Medicine Inspection 
Service responsible for sanitary control of establishments 
and health-related products, including the Cosmetic 
Industry (Brasil, 1953). Four years later, the National 
Service for Supervision of Medicine and Pharmacy 
(SNFMF) was approved, a member agency of the DNS 
with the function of coordinating and supervising the 
practice of medicine and correlated activities (Brasil, 
1957; Estefan, 1986; Rozenfeld, 2000).
The SNFMF was composed of professionals from 
the Chemical-Pharmaceutical Industry, Pharmacists, 
Teachers, Biologists and Physicians. This agency was 
responsible for the new substances or methods, including 
their chemical, pharmacological and therapeutic 
specifications; for establishing requirements about health 
issues linked to the industry; for the technical and scientific 
development of the industry; for issuing licenses to health 
establishment, including the Cosmetic Industries, and for 
the suspension of the license for a product marketed in 
disagreement with regulations (Brasil, 1957; Rozenfeld, 
2000).
The creation of the SNFN represented a milestone 
in the history of Brazilian Health Regulation because 
it was structured with the involvement of many health 
professionals, disseminating multidisciplinary knowledge 
about standards and guidelines for the regulation of 
industries, including the Cosmetic Industry.
This involvement of professionals and competent 
organs represented the beginnings of supervision of the 
marketing of safe cosmetic products, since the SNFMF 
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aimed to provide data about raw materials, including 
specifications, which could provide guidance about the 
use of safe and effective cosmetic ingredients. In this 
context, in 1961, Law No2312 was issued through Decree 
No49974-A, regarding the National Health Code (CNS), 
which established general rules for health protection. 
The National Health Code defined the State health 
requirements for each individual (Brasil, 1961).
The development of the CNS consolidated the 
trend in the country about the protection, promotion and 
restoration of health and regulated the sanitary control 
of the health establishments, including the Cosmetic 
Industries. Thus, the CNS represented a significant 
portion of the action of the Health Authorities regarding 
individual and collective health and included for the first 
time the standards and guidelines about industrial waste, 
representing an important action about environmental and 
health issues.
In 1976, as a result of the discussions of the 
safety of health-related products, Law No 6360 was 
published, later regulated by Decree No 79094 of 1977 
about Health Surveillance rules to which medicines, 
pharmaceutical, cosmetics and sanitizing products were 
submitted (Brasil, 1976, p. 1).This legislation provided the 
standards and guidelines for the licensing of the Cosmetic 
Industries, registration of cosmetic products, quality 
control, advertising, labeling, packaging, transportation 
of products, and information related to inspections, 
violations, penalties, and toxicity (Brasil, 1976).
The regulatory responsibilities of the cosmetic 
area, such as the issue of technical advice, licensing of 
establishments, inspection of facilities and application 
of punishments were centralized in the MS, which 
still had other responsibilities regarding public health 
(Brasil, 1976). .Also in 1976, the MS was restructured 
by Decree No 79056, with a redefinition of the organ and 
its competencies. It was established that the MS would 
be responsible for cosmetic norms and standards and the 
Health Surveillance Secretariat (SNVS) was established 
(Brasil, 1976).
Although not specifically concerning the cosmetic 
area, Law No 6360 was the first law containing important 
requirements and guidelines, which had not been 
previously described. The abolition of the use of toxic 
ingredients, an important requirement for the development 
of safe products, was also included. However, this was not 
enough to meet all needs of the cosmetic area.
The 70’s were also marked by the founding of the 
Brazilian Association of Cosmetology (ABC), a non-profit 
association for the development of National Cosmetology 
(ABC, 2015). The creation of the ABC also contributed 
to the regulation of shortcomings and guidance for the 
cosmetics area.
Moreover, in 1978 the SNVS was divided into 
specific departments such as the Division of Cosmetics 
(DICOP) containing the following services: Technical 
Analysis Service, Cosmetic Dermatology Service, 
Registration Service, Technical Documentation Service, 
and Inspection and Control Service (Brasil, 1978).
Thus, the DICOP was responsible for organizing, 
controlling and monitoring norms and standards related 
to cosmetic products (Brasil, 1978). However, according 
to the first DICOP publication in 1980, the cosmetic 
regulation was published together with the sanitation 
regulation (Brasil, 1980). This first publication concerned 
the substances that could be used in cosmetic products 
(Brasil, 1980). During the action of the DICOP, other 
ordinances were published, but none was directly related 
tothe safety and efficacy of these products, or Good 
Manufacturing Practices. However, Ordinance REC-2 in 
1981 presented criteria about the protection against tanning 
products (Brasil, 1981), Ordinances PRT-1 and PRT-2 in 
1982 and 1983, respectively, published information about 
lead acetate in cosmetic products (Brasil, 1982; 1983), and 
in 1985 for the first time an ordinance was published about 
preservatives that could be used in cosmetic products 
(Brasil, 1985).
Thus, the creation of the MS, so necessary for public 
health issues, resulted in the process of regulation of the 
Cosmetics Industry in Brazil, with a positive impact 
on the safety of the products marketed in this country. 
However, this process was not sufficient to regulate all 
relevant issues of the cosmetic area despite the creation 
of the DICOP.
The National Institute of Quality Control in Health 
(INCQS) was created in the early 80’s, with expertise in 
the areas of teaching, research and technology, quality 
control of raw materials, products, environments and 
services submitted to the action of Health Surveillance 
(Rozenfeld, 2000; FUNASA, 2004; 2014; INCQS, 
2014). The creation of the INCQS was important 
regarding actions of health surveillance for product 
control by laboratory analysis, using quality control 
methodologies.
Law No 8080 was then published in 1990, regulating 
the actions of public or private health services in the 
national territory, including the promotion, protection 
and restoration of health. In addition, the Unified Health 
System (SUS) became responsible for all of these actions 
(Brasil, 1990a; Rozenfeld, 2000). The Health Surveillance 
actions were also under the responsibility of the SUS 
(Brasil, 1990b).
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Also during the 1990’s, the Technical Regulation 
for the Inspection of Food Industries was approved by 
Ordinance No1428 of 1993. This Regulation approved 
the guidelines for Good Manufacturing Practices, and 
the implementation of quality standards for services and 
products in the food area (Brasil, 1993).
The sanitary regulation of the food area predicted 
what would happen later in the drug and cosmetic 
areas because it regulated the manufacturing processes 
according to quality standards, providing guideline for 
sanitary inspections and mainly for the safety of their 
products and their impact on consumer health.
Ordinance No 1556, based on Law No 8080, was 
published the following year, establishing the National 
Health Surveillance System (SNVS) coordinated by 
SUS, clarifying the responsibilities of the Federal 
Government, States, Federal District and cities regarding 
Health Surveillance and Epidemiological Surveillance 
(Brasil, 1994; Rozenfeld, 2000; Corrêa, 2003; Rediguieri, 
Rediguieri, Vieira, 2013).
Complementing the changes in Health Surveillance 
in the 90’s, in 1995, Ordinance No 17 was published, 
establishing the National Program for Inspection of 
Pharmaceutical and Pharmochemical Industries (PNIFF), 
and defining the conditions for the implementation of 
Good Manufacturing Practices for the Pharmaceutical 
and Pharmocheminal Industries, as well as importers and 
exporters (Eduardo, Miranda, 1998; Rozenfeld, 2000; 
Corrêa, 2003; Rediguieri, Rediguieri, Vieira, 2013).
Ordinance No 16 was published next, containing 
recommendations for the Pharmaceutical Industry for the 
implementation of Good Manufacturing Practices based 
on the “Guide to Good Manufacturing Practices” (Brasil, 
1995; Eduardo, Miranda, 1998; Rozenfeld, 2000; Corrêa, 
2003; Rediguieri, Rediguieri, Vieira, 2013).
Also in 1995, the Advisory Technical Committee on 
Cosmetics (CTAC) was established to provide advice on 
cosmetic products issues (ANVISA, 2004). The creation 
of CTAC was important by assisting the cosmetic area 
about issues mainly related to the safety of products. In 
addition, the Brazilian Association of Cosmetic, Toiletry 
and Perfumery Industries (ABIHPEC) was created in 
order to represent the Cosmetic Industry regarding its 
actionsandt progress in the country (ABIHPEC, 2015).
In line with the developments related to Good 
Manufacturing Practice, Ordinance No 327 of 1997 was 
published for the regulation of Good Manufacturing 
Practices in the Sanitation Industry (Brasil, 1997a).
Then, in 1997, Ordinance No348 was published the 
for the regulation of Good Manufacturing Practices in 
the Cosmetic Industries due to the need to update health 
control in the area of personal care products, cosmetics and 
perfumes. In addition, an Inspection Guide was available 
about sanitary inspections (Brasil, 1997b).
Ordinance No 348 was the first publication about 
Good Manufacturing Practices for the cosmetic area and 
also represented the last publication related to this area 
before the creation of the ANVISA.
The changes in the food, medicine and sanitation 
areas in the 90’s resulted in changes in the cosmetics area 
and also had a positive impact on the sanitary regulation 
of this area, in terms of safe cosmetic products, although 
no guidelines were provided about the necessary studies 
for the development of safe and effective products.
In short, important indirect regulatory milestones 
and a specific regulation marked the cosmetic area 
during the 20th century. However, despite the regulatory 
developments, mainly after the creation of MS, some 
problems still persisted, related to RD&I of safe 
and especially effective products. In addition, some 
requirements about safety were published, although 
without guidance about studies and methodologies.
Furthermore, as evaluated by Bellan et al. (2012), 
in a study on pharmaceutical legislation, it is important 
the participation of society, governmental agencies and 
industry on issues related to the regulation.
Finally, this study represents an important 
contribution to the cosmetic area because it provides data 
needed to understand the challenges faced by the Cosmetic 
Industry before ANVISA and shows the importance 
of a regulatory basis as technical support in the RD&I 
of cosmetic products, resulting in safe, effective and 
innovative products.
CONCLUSION
In this study, it was possible to conclude that the 20th 
century was marked by actions of the federal government 
in sanitary surveillance in Brazil, highlighting the sanitary 
movements, the creation of the Ministry of Health and the 
institution of the National Health Surveillance System.
In this context,  the cosmetic area also had 
regulatorymilestones, although it could also be concluded 
that the actions preceding the creation of ANVISA were 
insufficient, so that the area remained without requirements 
and guidelines about the development of safe products. The 
need for safe products was required, but only in 1946 and no 
other information about preclinical and clinical studies was 
published, which represented a challenge for the Cosmetic 
Industry at that time. In addition, no legislation or guidance 
about the efficacy of cosmetic products was detected, which 
also represented a challenge for the Cosmetic Industry. 
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Moreover, if not considered responsible, the industry could 
use claims without the need to support them with preclinical 
and clinical studies.
If on the one hand the events resulted in the creation 
of ANVISA, on the other the challenges faced by the 
Cosmetic Industry at that time could have a negatively 
impact on the health of the consumers of these products. 
Thus, the creation of ANVISA was essential to meet the 
challenges of the cosmetic area related to the safety and 
efficacy of its products.
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